Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the independently assessed progression free survival of subjects with clear cell type renal cell carcinoma (all risk groups) treated with bevacizumab + temsirolimus (experimental) versus bevacizumab + interferon-alfa (control) in subjects with advanced renal cell carcinoma.
Critère d'inclusion
- First-Line Treatment in Subjects with Advanced Renal Cell Carcinoma